UK committee recommends HPV vaccination for MSM

Kirby, Tony

doi:10.1016/s1470-2045(14)71128-3

Cited by 12 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Currently HPV vaccination for adolescent boys is only recommend by a few, including America, Canada, Australia and Austria. Furthermore, the UK's Joint Committee on Vaccination and Immunisation has recently recommended that men who have sex with men (aged 16–40 years) should also be offered the HPV vaccine 44. The cost-effectiveness of the vaccine has been debated as the rational against vaccinating adolescent boys 44.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, the UK's Joint Committee on Vaccination and Immunisation has recently recommended that men who have sex with men (aged 16–40 years) should also be offered the HPV vaccine 44. The cost-effectiveness of the vaccine has been debated as the rational against vaccinating adolescent boys 44. Moreover it has been argued that boys will receive a degree of protection from the herd immunity effect of vaccinated girls.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review

et al. 2016

View full text Add to dashboard Cite

BackgroundThe human papillomavirus (HPV) vaccine is recommended for adolescent girls in many European countries, however there is huge variation in vaccine uptake. Methods A mixed methods systematic review to ascertain the level of HPV and HPV vaccine knowledge that exists among European adolescents. Two electronic databases, Ovid Medline and PsychInfo, were searched from origin to September 2014. Meta-analysis was performed for the two primary outcome measures ('have you heard of HPV?' and 'have you heard of the HPV vaccine?'), assessing for the correlation between gender and knowledge. This was supplemented with meta-synthesis for the remaining associations and secondary outcomes. Results 18 papers were included in the final review. Overall European adolescents had poor understanding of basic HPV and HPV vaccine knowledge. Meta-analysis identified that female adolescents are more likely to have heard of HPV (n=2598/5028 girls versus n=1033/3464 boys; OR 2.73, 95% CI 1.86-3.99) and the HPV vaccine (n=1154/2556 girls versus n=392/2074 boys; OR 5.64, 95% CI 2.43-13.07), compared to males. Age, higher education and a positive vaccination status were also associated with increased awareness. There was limited appreciation of more detailed HPV knowledge and uncertainty existed regarding the level of protection offered by the vaccine and the need for cervical screening post vaccination. Conclusions The delivery of HPV education to European adolescents needs to be re-evaluated, since at present there appears to be significant deficiencies in their basic knowledge and understanding of the subject. Increasing HPV knowledge will empower adolescents to make informed choices regarding participation with HPV related cancer prevention health strategies.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review

et al. 2016

View full text Add to dashboard Cite

show abstract

“…[62][63][64][65][66] The United Kingdom also recently took a position in favor of targeted vaccination for MSM from 16 to 40 years of age. 3 …”

Section: Conformity With Other Jurisdictionsmentioning

confidence: 99%

“…Unlike heterosexual men, MSM cannot count on the herd immunity provided by the vaccination of girls. The Quebec Immunization Committee (CIQ) and several other advisory boards [1][2][3][4] recommend vaccination of preadolescent boys, as the best approach to maximize the protection of men and particularly MSM. According to most analyses adding the vaccination of all preadolescent boys could produce benefits.…”

Section: Introductionmentioning

confidence: 99%

“…Introducing a free vaccination program for preadolescent boys may still be justified by political considerations or the desire for equity, to provide boys and especially MSM with direct protection. 1,3,5,6 The possibility of setting up a targeted vaccination program for MSM, which means, to offer the vaccine for free only to male who claim to have sex with men, was also envisioned by different advisory committees, particularly in areas where no HPV vaccination program for boys is in place. To our knowledge, this is the first review summarizing the data on HPV vaccination for MSM.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

HPV Vaccination for MSM: Synthesis of the evidence and recommendations from the Québec Immunization Committee

Sauvageau

Dufour-Turbis

2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Diseases associated with the human papilloma virus (HPV) are particularly common among men who have sex with men (MSM). Unlike heterosexual men, MSM do not benefit from the herd protection provided by the vaccination of girls. In this review, we synthesize the available evidence on HPV vaccination for MSM. We also present the recommendations of the Quebec Immunization Committee (CIQ) in this regard, which are: to provide targeted vaccination for MSM up to 26 years of age and in-school vaccination of preadolescent boys since this is the best approach to take to have a real impact on the burden related to HPV in the MSM population and to provide direct protection for all men.

show abstract

A Dynamic Model to Assess Human Papillomavirus Vaccination Strategies in a Heterosexual Population Combined with Men Who have Sex with Men

et al. 2021

View full text Add to dashboard Cite

UK committee recommends HPV vaccination for MSM

Cited by 12 publications

References 0 publications

Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review

Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review

HPV Vaccination for MSM: Synthesis of the evidence and recommendations from the Québec Immunization Committee

A Dynamic Model to Assess Human Papillomavirus Vaccination Strategies in a Heterosexual Population Combined with Men Who have Sex with Men

Contact Info

Product

Resources

About